Delivery Order SPE2DB24D1205-SPE2DB25FDAEQ
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,786.70 on May 8, 2025, for the supply of Synthroid 50 microgram tablets in quantities of 1,000 units. This non-competitive, firm fixed-price delivery order is set to be completed by May 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Synthroid 25 MCG tablets (1,000 count) on July 22, 2025, with a ceiling value of $1,090.43. The contract employs firm fixed price pricing and is scheduled for ultimate completion by July 23, 2025. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of 1,000 tablets of Synthroid 100 microgram at a ceiling value of $3,713.41. This non-competitive delivery order represents a firm fixed-price contract with an ultimate completion date of July 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract is issued as a child order under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 75 mcg on June 17, 2025, with a ceiling value of $1,886.88. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract includes no set-aside designation, reflecting AmerisourceBergen's competitive standing in federal pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Synthroid 100 micrograms tablets in quantities of 1,000 units, with a ceiling value of $1,061.94. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is due for completion by September 16, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,931.37 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 micrograms. The contract, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Synthroid 100 microgram tablets in quantities of 1,000 units, with a ceiling value of $1,678.76. This non-competitive, firm fixed price delivery order is set to be completed by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for 1,000 tablets of Synthroid 150 micrograms with a ceiling value of $1,575.33. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is due for ultimate completion on September 16, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Synthroid 137 micrograms, valued at $55,921.07, with an ultimate completion date of July 1, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order represents a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,630.09 to AmerisourceBergen Drug Corp for the supply of Synthroid 50 MCG tablets (1,000 units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order under the competitive procurement process. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAEQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Synthroid 88 mcg tablets in quantities of 1,000 units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,510.44 with firm fixed pricing and an ultimate completion date of September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor for the federal government, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military and veteran healthcare systems. The Synthroid order fulfills critical pharmaceutical needs within the Defense Health Agency's broader medical supply chain, demonstrating the contractor's role as a key distributor of brand-name and generic medications for federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/5/25 |